UK markets close in 3 hours 5 minutes

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
111,500.00-500.00 (-0.45%)
At close: 03:30PM KST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,626,643,816
1,626,643,816
1,711,312,740
1,537,825,750
1,504,115,279
Cost of revenue
1,142,011,053
1,142,011,053
1,129,508,276
1,017,232,478
1,063,488,669
Gross profit
484,632,763
484,632,763
581,804,463
520,593,272
440,626,609
Operating expenses
Research development
173,487,000
173,487,000
191,347,000
146,030,000
137,987,000
Selling general and administrative
134,402,593
134,402,593
165,070,797
169,126,651
145,241,084
Total operating expenses
450,191,593
450,191,593
500,540,797
446,857,651
390,342,084
Operating income or loss
34,441,170
34,441,170
81,263,666
73,735,621
50,284,525
Interest expense
28,483,187
28,483,187
18,392,691
12,501,240
10,354,000
Income before tax
-27,134,763
-27,134,763
85,727,860
172,559,286
104,473,503
Income tax expense
-7,326,032
-7,326,032
16,313,075
35,609,407
15,365,726
Income from continuing operations
-19,808,731
-19,808,731
69,414,785
136,949,879
89,107,777
Net income
-26,631,783
-26,631,783
65,453,134
123,211,806
81,048,858
Net income available to common shareholders
-26,631,783
-26,631,783
65,453,134
123,211,806
81,048,858
Basic EPS
162.00
-
5.74k
10.80k
7.10k
Diluted EPS
162.00
-
5.74k
10.80k
7.10k
Basic average shares
11,414
-
11,413
11,413
11,414
Diluted average shares
11,414
-
11,413
11,413
11,414